Business Context and Reporting Period
Company: American Vanguard Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: March 5, 2008
Reporting Period: The filing references financial results for the quarter and full year ended December 31, 2007, and the completion of an asset acquisition on March 5, 2008.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release attached as Exhibit 99.1, which is incorporated by reference but not reproduced in the provided text.
Material Changes and Events
- Financial Results Announcement: The company announced its fourth quarter and full-year 2007 financial results via a press release (Exhibit 99.1).
- Asset Acquisition: The company completed the acquisition of substantially all assets of the production facility located in Marsing, Idaho (the "Marsing Facility"), previously owned by Bayer Cropscience LP.
Guidance, Outlook, and Risks
The filing text does not contain specific guidance, outlook, management commentary, or risk factors. It serves primarily as a notification of the release of financial results and the completion of the Marsing Facility acquisition. The document includes a standard disclaimer that the information is furnished under Items 2.02 and 8.01 and is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 for specific revenue, earnings, and cash flow figures for Q4 and full-year 2007.
- Examine Exhibit 99.2 for details regarding the purchase price, terms, and strategic impact of the Marsing Facility acquisition.
- Verify the integration timeline and expected operational benefits of the newly acquired Idaho production facility.
- Confirm if the acquisition impacts the company's debt levels or liquidity position as detailed in the full financial statements.